TERUMO INTERVENTIONAL SYSTEMS

Telumo Gloabal
Ultimaster™
Ultimaster™ Tansei™
Contact
EMEA
APAC
Latin America
Clinical Evidence
CENTURY II Bifurcation sub-group
CENTURY II Multivessel disease
CENTURY II Total population
DISCOVERY 1TO3
e-Ultimaster Bifurcation sub group
e-Ultimaster Left Main sub group
e-Ultimaster Total population
MASTER DAPT
MODEL U-SES

How MASTER DAPT can help you decide the optimal short DAPT duration

- with clinical expert Dr. Muramatsu

S0_Ready to get started? Sign up now!

S0_Lorem ipsum dolor sit amet

S0_2-Col, Right Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

Lorem ipsum dolor sit amet, consectetur adipisicing, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut. Ut ad minim veniam.

Vestibulum ante ipsum primis in faucibus orci luctus etel ultrices posuere cubilia Curae.

S0_Lorem ipsum dolor sit amet, consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

S1_Lorem ipsum dolor sit amet, consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

S1_2-Col, Right Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

Lorem ipsum dolor sit amet, consectetur adipisicing, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut. Ut ad minim veniam.

Vestibulum ante ipsum primis in faucibus orci luctus etel ultrices posuere cubilia Curae.

S1_2-Col, Left Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

  • Many addon features
  • Fully responsive & adaptive
  • SEO optimized
  • Attractive with a modern touch
  • Full Support

S1_Ut Enim Minima

Sed ut perspiciatis unde omnis iste natus error sit voluptatem!

Quis Autem Vel

Nemo enim ipsam voluptatem quia voluptas sit odit aut fugit!

Quo Voluptas

Ut enim ad minima veniam, quis nostrum exercitationem ullam!

Are you a healthcare professional interested in short DAPT?
Do you want to learn more about…

What

The MASTER DAPT trial is and how is applies to short DAPT?

Why

The MASTER DAPT trial is different to other clinical studies on short DAPT?

How

A short DAPT protocol fits with established guidelines?

S1_Lorem ipsum dolor sit amet

Watch the full Interview with Dr. Muramatsu

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

S2_2-Col, Right Image

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut.

Lorem ipsum dolor sit amet, consectetur adipisicing, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut. Ut ad minim veniam.

Vestibulum ante ipsum primis in faucibus orci luctus etel ultrices posuere cubilia Curae.

summary download

Summary download for optimal DAPT protocol

The interview is in five parts and takes a total of 25 minutes to watch. A summary of the interview can be simple to confirm . You can download it in full here.

S2_Ut Enim Minima

Sed ut perspiciatis unde omnis iste natus error sit voluptatem!

Quis Autem Vel

Nemo enim ipsam voluptatem quia voluptas sit odit aut fugit!

Quo Voluptas

Ut enim ad minima veniam, quis nostrum exercitationem ullam!

S2_Consectetur adipiscing elit...

Joanna C.

"Et harum quidem rerum facilis est et expedita distinctio!"

Stanley T.

"Nam libero tempore, cum soluta nobis est eligendi."

Danielle W.

"Temporibus autem quibusdam et aut officiis debitis!"

S2_Lorem ipsum dolor sit amet

Overview of the MASTER DAPT Trial

Gain an understanding of the MASTER DAPT trial results, as Dr. Muramatsu reviews the design, endpoints, conclusions and more.

Behind the MASTER DAPT study

Update your knowledge on recent short DAPT guidelines as Dr. Muramatsu looks at guidelines in US, EU and Japan.

img-masterdapt-dr-muramatsu-awareness-2-background-600x400.png

Behind the MASTER DAPT Trial

Learn how the MASTER DAPT trial differs to other short DAPT studies, as Dr. Muramatsu introduces the trial’s background and its main considerations.



Short DAPT Guidelines across the Globe

Update your knowledge on recent short DAPT guidelines as Dr. Muramatsu looks at guidelines in US, Europe and Japan.



How do you decide the duration for short DAPT?

- Short DAPT in Practice -
Learn how to decide a short DAPT duration, as Dr. Muramatsu shares the short DAPT protocol at his hospital before and after the MASTER DAPT trial.



What is the future of short DAPT?

- Tools and Techniques for Short DAPT -
Find out which tools can help improve patient wellbeing in short DAPT, as Dr. Muramatsu shares his opinion on the importance of drug eluting stents in a short DAPT procedure.

Read more about the MASTER DAPT Trial


Get the trial result

The latest results of MASTER DAPT

Read the latest results from the MASTER DAPT Complex PCI sub-analysis published at EuroPCR2022 >


Get the trial result

Summary report of main trial about MASTER DAPT

Read the summary report of the MASTER DAPT main trial result >


Get the trial result

Sub-analysis of MASTER DAPT: OAC

Read the summary report for the MASTER DAPT OAC sub-analysis result >

S3_Lorem ipsum dolor sit amet

img-product-ultimaster-600x400.png

UltimasterTM

Terumo’s proprietary bioresorbable polymer coating and two-link design help facilitate smoother access. Discover how the UltimasterTM stent can ensure optimal deliverability and potentially shortened DAPT time.

Disclaimer

MASTER DAPT trial is sponsored by the European Cardiovascular Research Institute (ECRI, Rotterdam, The Netherlands) and supported with a restricted research grant by Terumo Europe. The study is managed by global CROs and data management group (CERC, Paris, France, Cardialysis, Rotterdam, The Netherlands, CV quest. Co. Ltd., Tokyo, Japan and CTU, Bern, Switzerland).

img-left-md-webinarinfo-800x500.png

New MASTER DAPT Webinars to Optimize your DAPT StrategyNew MASTER DAPT Webinars to Optimize your DAPT Strategy

The results of the MASTER DAPT study proved the non-inferiority of short DAPT, and helped bridge the current knowledge gap on DAPT duration in high bleeding risk patients. Understand the potential impact on DAPT guidelines and how to select the optimal DAPT duration for your patients with our collection of MASTER DAPT webinars from around the globe.

Want to know more?

Contact us with you questions about Terumo products and learning resources. Our sales representatives are happy to help.